Omnicell supplies medication management hardware and software that automate how hospitals and health systems store, dispense, and track drugs across pharmacies and nursing units. Its portfolio includes automated dispensing cabinets, central pharmacy robotics, IV compounding tools, and related software for inventory control and adherence. Customers are primarily acute-care providers seeking to reduce medication errors and improve pharmacy workflow efficiency.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 269.7 | — | -7 | — |
| Q2 2025 | 290.6 | — | 5.6 | — |
| Q3 2025 | 310.6 | — | 5.5 | — |
| Q4 2025 | 314 | — | -2 | — |
| Q1 2026 | 309.9 | 14.9% | 11.4 | — |
| Q2 2026 | 312.2 | 7.5% | 24.3 | 330.7% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Alphatec Holdings, Inc. (ATEC), ICF International, Inc. (ICFI), Intellia Therapeutics, Inc. (NTLA), Hycroft Mining Holding Corporation (HYMC), Weibo Corporation (WB), Opera Limited (OPRA)